Overview

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety and efficacy of an investigational agent administered in addition to a standard anti-emetic regimen for the treatment of chemotherapy induced nausea and vomiting.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Aprepitant
Casopitant
Dexamethasone
Fosaprepitant
Ondansetron